-- Scott Roberts
WEDNESDAY, May 29 (HealthDay News) -- The first device to use
Radio Frequency Identification (RFID) technology to help workers
track blood products and prevent the release of unsuitable samples
has been approved by the U.S. Food and Drug Administration.
The iTrace for Blood Centers device uses a memory-storage chip
on the item being tracked. In addition to barcode identification
systems already in place, the new device provides another layer of
protection in product tracking, the agency said in a news
The device can track information including a product code, blood
type and expiration date, the FDA said.
iTrace is manufactured by SysLogic Inc., based in Brookfield,
The FDA has more about
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.